IMMUNOGENICITY AND SAFETY OF HOMOLOGOUS CHADOX1 NCOV-19 AND HETEROLOGOUS PRIME-BOOST OF CORONAVAC AND CHADOX1 NCOV-19 AMONG KIDNEY TRANSPLANT RECIPIENTS: AN OBSERVATIONAL PROSPECTIVE COHORT STUDY
Back
Abstract Number
WCN23-1041
Categories
Special Covid-19
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Covid-19 and Kidney Failure (Former ESKD)
Topic - Education
Abstract Title
IMMUNOGENICITY AND SAFETY OF HOMOLOGOUS CHADOX1 NCOV-19 AND HETEROLOGOUS PRIME-BOOST OF CORONAVAC AND CHADOX1 NCOV-19 AMONG KIDNEY TRANSPLANT RECIPIENTS: AN OBSERVATIONAL PROSPECTIVE COHORT STUDY
Co-authors
Narongkiatikhun, P.(1)*;Ophascharoensuk, V.(1);Chaiwarith, R.(1);Winichakoon, P.(1);Vongsanim, S.(1);Suteeka, Y.(1);Pogsuwan, K.(1);Kusirisin, P.(1);Wongsarikan, N.(1);Khamwan, C.(2);Dankai, D.(2);Noppakun, K.(1);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Faculty Of Medicine- Chiang Mai University, Internal Medicine, Chiang Mai, Thailand;(2)Faculty Of Medicine- Chiang Mai University, Immunology Laboratory- Diagnostic Laboratory, Chiang Mai, Thailand;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/124797e4a7699d9f85314a98b7e4f4bb.pdf
Audio File
if any